A Comparative Performance Assessment of Optimized Multilevel Ensemble Learning Model with Existing Classifier Models.

To predict the class level of any classification problem, predictive models are used and mostly a single predictive model is built to predict the class level of any classification problem; current research considers multiple predictive models to predict the class level. Ensemble modeling means instead of building a single predictive model, it is proposed to build a multilevel predictive model, which generalizes to predict all the class levels with an adequate percent of accuracy, that is, from 70% to 90% by applying and using a different combination of classification algorithms. In this article, a multilevel approach for selecting base classifiers for building an ensemble classification model is proposed.

Effect of rifaximin, probiotics, and l-ornithine l-aspartate on minimal hepatic encephalopathy: a randomized controlled trial.

Background/aims: Minimal hepatic encephalopathy (MHE) implies subtle impairment of cognitive functions in the absence of features of overt encephalopathy. We aimed to determine the prevalence of MHE in patients with liver cirrhosis and to find out the effect of rifaximin, probiotics, and l-ornithine l-aspartate (LOLA) individually in reversal of MHE by comparing it with placebo group.

Patients And Methods: This study was carried out in two phases.

Distribution of hepatitis B virus genotypes and its association with severity of liver disease in patients with chronic hepatitis B in uttar pradesh, India.

The present study was designed to investigate the distribution of genotypes and its association with severity of liver disease in patients with Chronic Hepatitis B (CHB) in Uttar Pradesh, India. One hundred five HBsAg positive patients were selected for the study. The DNA was extracted by using pure viral DNA extraction kit.

Clinical profile, genotype and management updates of hepatitis B virus.

Hepatitis B virus (HBV) is a well known agent of acute and chronic hepatitis, liver cirrhosis and hepatocellular carcinoma. Around 400 million people worldwide carrier of HBV of which more than 250 million reside in Asia, and 1-2 million people have died from it. It has a partially double-stranded DNA, having 3.

Identification of a hepatitis B virus core promoter mutant by PCR- RFLP in patients suffering from chronic liver disease, Uttar Pradesh, India.

Objective: The present study was designed to identify a core promotor mutation in the HBV genome in patients suffering from HBV related chronic liver disease.

Materials And Methods: 154 chronic liver disease patients were selected for study of DNA extracted using a pure viral DNA extraction kit. The core promoter mutation was detected by the polymerase chain reaction- based restriction fragment length polymorphism (PCR-RFLP) method, using the Sau 3AI restriction enzyme to see if cleavage would occur at this specific site.

Significance of alanine aminotransferase testing in diagnosis of acute and chronic HBV infection.

Hepatitis B is a major public health problem world wide; more than 350 million people have chronic infection. Diagnosis of hepatitis is made by biochemical assessment of liver function. Alanine aminotransferase (ALT), a liver enzyme, is markedly elevated in hepatitis and with other causes of acute liver damage associated with hepatic necrosis, blood levels being elevated even before the clinical signs and symptoms of disease such as jaundice appear.